×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Worldwide schedules comment Share
7865 views

Animateurs:

  • Dr Gwenaël Ferron, chirurgien oncologue Institut Universitaire du Cancer Toulouse
  • Coralie Marjollet, Imagyn

La Société Française de Chirurgie Oncologique s’associe à l’association IMAGYN pour un webinar ONCOSTREAM sur les Tumeurs Rares de l'Ovaire à destination des patientes et des professionnels de santé.

Quelques exemples des thèmes qui seront abordés lors de cette réunion interactive entre oncologues experts du groupe GINECO, spécialistes de soins de support et les patientes :

  • Qu'est-ce qu'une tumeur rare de l'ovaire ?
  • Pourquoi cela touche des femmes jeunes voire des adolescentes ?
  • Quels sont les traitements proposés et pourquoi ?
  • Comment prévenir et prendre en charge les séquelles de traitements, en particulier la fertilité, la ménopause, la sexualité ?
  • Comment accompagner au mieux les patientes et leurs familles? Place de l'association de patientes IMAGYN
  • Quel est le rôle du réseau de centres experts TMRO ?

Afin de pouvoir poser vos questions en direct aux intervenants un chat sera mis à votre disposition.

Shooting date : 2021-05-10
Last update : 2024-02-13
1 comment
Join the Discussion
  • Lauriane G. merci pour la presentation

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, June 18th 2024 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, June 18th 2024 from 10am to 11:30am (GMT+2)
    New York : Tuesday, June 18th 2024 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, June 18th 2024 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, June 18th 2024 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, June 18th 2024 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, June 18th 2024 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, June 18th 2024 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, June 19th 2024 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, June 19th 2024 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, June 19th 2024 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, June 19th 2024 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, June 19th 2024 from 06am to 07:30am (GMT+2)

    La qualité de vie

    et le cancer de l'ovaire

    Share
    Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, January 31st 2023 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, January 31st 2023 from 09am to 10:30am (GMT+1)
    New York : Tuesday, January 31st 2023 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, January 31st 2023 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, January 31st 2023 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, January 31st 2023 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, February 1st 2023 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, February 1st 2023 from 05am to 06:30am (GMT+1)

    Cancer de l'ovaire en 1L :

    Actualités et options thérapeutiques disponibles en 2023

    Share
    Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, October 16th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Monday, October 16th 2023 from 10am to 11:30am (GMT+2)
    New York : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Monday, October 16th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Monday, October 16th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Tuesday, October 17th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Tuesday, October 17th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Tuesday, October 17th 2023 from 06am to 07:30am (GMT+2)

    La nouvelle classification des cancers de l’endomètre en pratique

    Cycle d'enseignement - Les cancers gynécologiques

    Share
    Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Honolulu : Wednesday, March 20th 2024 from 08am to 09am (GMT+1)
    San Francisco : Wednesday, March 20th 2024 from 10am to 11am (GMT+1)
    New York : Wednesday, March 20th 2024 from 01pm to 02pm (GMT+1)
    Buenos Aires : Wednesday, March 20th 2024 from 03pm to 04pm (GMT+1)
    London / Dublin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
    Paris / Berlin : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Istanbul : Wednesday, March 20th 2024 from 08pm to 09pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 20th 2024 from 10pm to 11pm (GMT+1)
    Bangkok : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
    Shanghai : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
    Tokyo : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
    Sydney : Thursday, March 21st 2024 from 04am to 05am (GMT+1)
    Wellington : Thursday, March 21st 2024 from 06am to 07am (GMT+1)

    Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

    éclairages du congrès de la SGO

    Share
    Scroll Up